(EMAILWIRE.COM, September 18, 2019 ) Fill Finish Manufacturing is the process of aseptically filling biologics in any form such as solution, powder, or suspension in containers such as vials, syringes, cartridges, ampoules, bottles, and bags. It is an integral part of biopharmaceutical manufacturing after upstream-cell culture & downstream-separation and purification operations. Key steps involved in the fill-finish process include cleaning, sterilization, filling, stoppering, lyophilization, capping, crimping, and visual inspection.

Technological advancements in fill-finish products, growth of the biopharmaceutical industry, rising adoption of prefilled syringes, and increase in fill-finish outsourcing are the major factors driving this market.

The global fill-finish manufacturing market is estimated to account for USD 2.96 Billion in 2017 and projected to reach USD 4.47 Billion by 2022, at a CAGR of 8.6%.

In 2017, Europe is expected to account for the largest share of the global fill-finish manufacturing market. The large share of the European region is mainly attributed to factors such as the emergence of biosimilar market due to patent expiry of key biologic products, rising incidence of chronic disorders, and increasing focus of major players on enhancing their presence in Europe.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

The APAC region is expected to grow at the highest CAGR over the next five years. The growth of the fill-finish manufacturing market in this region is fueled by the overall growth in the biopharmaceutical industry.

Product launches remain at the center of the strategic growth initiatives adopted by a majority of key players in the global fill-finish manufacturing market. Companies such as Schott (Germany), Stevanato (Italy), Gerresheimer (Germany), Robert Bosch (Germany), and Becton, Dickinson and Company (US) have been focusing on product launches to enhance their market presence. Players also focused on increasing their presence in high-growth markets through inorganic growth strategies, such as partnerships, collaborations, agreements, expansions, and acquisitions.

Becton, Dickinson and Company (US) is the dominant player in the global fill-finish manufacturing market. The company offers a wide range of products in the market which includes consumables, such as pre-filled syringes. For instance, in 2016, BD expanded its production facility in Hungary. The company invested approximately USD 121 million (EUR 110 million) to provide additional production lines for prefilled syringes and plastic security devices. In the same year, the company also launched its BD Neopak 2.25 mL prefillable glass syringe. With its strong geographic presence and extensive product portfolio, the company is expected to witness strong growth in the fill-finish manufacturing market during the forecast period. The company focuses on organic strategies to maintain its position in the market.

Robert Bosch (Germany) is another leading player operating in the fill-finish manufacturing market. The company offers an extensive product portfolio in the market through its Industrial Technology business segment. For instance, in 2016, Robert Bosch launched a new filling and closing machine AFG 5000. The company focuses on product innovation to strengthen its position in the market. The company offers qualitative and innovative products to its end users. Robert Bosch has a strong geographic presence across the Americas, Asia, Africa, Europe, and Australia.

Read More@
https://www.marketsandmarkets.com/PressReleases/fill-finish-manufacturing.asp

Some other leading players in the global fill-finish manufacturing market include West Pharmaceutical Services (US) Gerresheimer AG (Gerresheimer) (Germany), IMA (Italy), OPTIMA (Germany), and Nipro Medical Corporation (US). These companies have well-established sales and distribution networks across the globe. They also make significant investments in R&D activities to develop innovative technologies and products. Focus on innovation plays an important role in this market.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com